デフォルト表紙
市場調査レポート
商品コード
1293532

血小板リッチ血漿市場:供給源タイプ別(同種、自家、同種)、用途別(美容外科、一般外科、脳神経外科)-2023-2030年の世界予測

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Application (Cosmetic Surgery, General Surgery, Neurosurgery) - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
血小板リッチ血漿市場:供給源タイプ別(同種、自家、同種)、用途別(美容外科、一般外科、脳神経外科)-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血小板リッチ血漿の世界市場は、2023年には3億8,163万米ドル、CAGR12.34%で大きく成長し、2030年には8億4,854万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の血小板リッチ血漿市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.血小板リッチ血漿の世界市場規模および予測は?

2.予測期間中、世界の血小板リッチ血漿市場を形成するCOVID-19の阻害要因と影響は?

3.血小板リッチ血漿の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.血小板リッチ血漿の世界市場における競争戦略は?

5.血小板リッチ血漿の世界市場における技術動向と規制の枠組みは?

6.血小板リッチ血漿の世界市場における主要ベンダーの市場シェアは?

7.血小板リッチ血漿の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界的にスポーツ関連の怪我の発生率が増加
      • 筋骨格疾患および整形外科疾患の治療における応用の可能性
      • 美容整形や自然治癒プロセスでの使用が増加
    • 抑制要因
      • 血小板リッチ血漿の治療効果に関する不確実性
    • 機会
      • 再生医療における新たな応用
      • 多血小板血漿由来の生理活性分子に関する継続的な研究開発活動
    • 課題
      • 多血小板血漿製剤の臨床試験および償還ポリシーの利用可能性の制限
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 血小板リッチ血漿市場ソースタイプ別

  • 同種異系
  • 自己由来
  • 相同

第7章 血小板リッチ血漿市場:用途別

  • 美容整形
  • 一般外科
  • 脳神経外科
  • 整形外科

第8章 南北アメリカの血小板リッチ血漿市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の血小板リッチ血漿市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの血小板リッチ血漿市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2030 (%)
  • FIGURE 5. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. PLATELET RICH PLASMA MARKET DYNAMICS
  • FIGURE 8. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. PLATELET RICH PLASMA MARKET LICENSE & PRICING
目次
Product Code: MRR-035AB9C0DA85

The Global Platelet Rich Plasma Market is forecasted to grow significantly, with a projected USD 381.63 million in 2023 at a CAGR of 12.34% and expected to reach a staggering USD 848.54 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Platelet Rich Plasma Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Platelet Rich Plasma Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Source Type, market is studied across Allogenic, Autologous, and Homologous. The Autologous commanded largest market share of 44.31% in 2022, followed by Homologous.

Based on Application, market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery. The General Surgery commanded largest market share of 22.35% in 2022, followed by Neurosurgery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.64% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Platelet Rich Plasma Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Platelet Rich Plasma Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Platelet Rich Plasma Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Platelet Rich Plasma Market?

4. What is the competitive strategic window for opportunities in the Global Platelet Rich Plasma Market?

5. What are the technology trends and regulatory frameworks in the Global Platelet Rich Plasma Market?

6. What is the market share of the leading vendors in the Global Platelet Rich Plasma Market?

7. What modes and strategic moves are considered suitable for entering the Global Platelet Rich Plasma Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Platelet Rich Plasma Market, by Source Type, 2022 vs 2030
  • 4.3. Platelet Rich Plasma Market, by Application, 2022 vs 2030
  • 4.4. Platelet Rich Plasma Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
      • 5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
      • 5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Application in Regenerative Medicine
      • 5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic Surgery
  • 7.3. General Surgery
  • 7.4. Neurosurgery
  • 7.5. Orthopedic Surgery

8. Americas Platelet Rich Plasma Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Platelet Rich Plasma Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

1. APEX Biologix, LLC

2. Arthrex, Inc.

3. Biotest AG

4. Celling Biosciences, Inc.

5. China Biologic Products Holdings, Inc.

6. CSL Limited

7. Dr PRP USA LLC

8. Eclipse

9. EmCyte Corporation

10. Estar Technologies Ltd.

11. Exactech, Inc.

12. Glofinn Oy

13. Johnson & Johnson

14. Juventix Regenerative Medical, LLC

15. Stryker Corporation

16. Terumo BCT, Inc.

17. ThermoGenesis Holdings, Inc.

18. Zimmer Biomet Holdings, Inc.